- Home
- »
- Medical Devices
- »
-
Platysmaplasty Treatment Market Size Report, 2026-2033GVR Report cover
Platysmaplasty Treatment Market (2026 - 2033)
Size, Share & Trends Analysis Report By Gender (Male, Female), By End Use (Cosmetic Surgery Clinics, Hospitals), By Region (North America, Asia Pacific, Europe, Latin America, Middle East & Africa), And Segment Forecasts
Market Size, 2025
$1.3BMarket Estimate, 2026
$1.4BMarket Forecast, 2033
$2.3BCAGR, 2026–2033
7.5%Platysmaplasty Treatment Market Summary
The global platysmaplasty treatment market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.4 billion in 2026 to USD 2.3 billion in 2033, at a CAGR of 7.5% from 2026 to 2033. North America dominated the global market, accounting for the largest revenue share of 35.0% in 2025. The market is experiencing robust growth, driven by strong demand for cosmetic procedures to improve the appearance of the neck and jawline.
Key Market Trends & Insights
- By gender: The female segment dominated the market with approximately 60.0% revenue share in 2025.
- By end use: The cosmetic surgery clinics segment dominated the market in 2025 with a share of more than 60.0%.
Regional Insights
- Largest regional market: North America (35.0% revenue share, 2025)
- Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)
Market Size & Forecast
- Market size in 2025: USD 1.3 Billion
- Estimated market size in 2026: USD 1.4 Billion
- Projected market size by 2033: USD 2.3 Billion
- CAGR (2026-2033): 7.5%
Three ways to get this report
Buy it, customize it, or ask a question.Ask an Analyst
Analyst response in 1 business day
- AccessReport author, directly
- Reply timeWithin 1 working day
- No sales callDirect answer only
- FormatEmail reply
- CostFree, no cost
Get the Full Report
What the study covers
- FormatsPDF · Excel · Dashboard
- Timeline2026–2033 annual, 2025 base
- Coverage20+ countries, 5 regions
- Companies10+ key players profiled
Customize the Report
20% free customization
- IncludeCountries, segments, points
- TailorTo your product definition
- ExtendDeeper competitor detail
- OrA fully bespoke study
- Turnaround5–10 working days
Platysmaplasty, a surgical procedure primarily focused on correcting and enhancing the neck and jawline, involves tightening the platysma muscles responsible for neck and jowl sagging, resulting in a more youthful and well-defined neck contour. The growth can be attributed to factors such as the increasing emphasis on physical appearance and youthfulness, rising disposable incomes, and advancements in surgical techniques. These factors contribute positively to market growth, driven by increasing awareness of aesthetic procedures and the desire to maintain a youthful appearance.
Source: Grand View Research, IR Documents, Primary Interviews, Paid DatabasesTo learn more about this report,Download Free Sample Report
This trend is particularly evident in the rising interest in platsymaplasty surgeries, which specifically target neck and jawline enhancement. According to the American Society of Plastic Surgeons (ASPS) 2024 Plastic Surgery Statistics Report, neck lift procedures recorded a 2% year-over-year increase in 2024, making them one of the rapidly growing facial cosmetic surgeries as patients seek solutions to address neck laxity and improve jawline definition. This further supports the growing demand for neck rejuvenation procedures. Rising awareness of their overall appearance and the need to achieve a youthful, attractive look continue to drive demand for plastic surgery, indicating the importance of these procedures in supporting the market growth.
The platysmaplasty treatment industry is poised for expansion, driven by advances in cosmetic surgery technologies and techniques. For instance, in June 2025, Allergan Aesthetics, an AbbVie Inc., announced that the U.S. Food and Drug Administration (FDA) accepted for review its supplemental premarket approval (sPMA) application for SKINVIVE by JUVEDERM to improve neck appearance. If approved, the product would become the first hyaluronic acid injectable treatment specifically indicated to reduce neck lines, reflecting continued innovation in neck rejuvenation and aesthetic treatment solutions.
Moreover, the market benefits from a growing number of skilled plastic surgeons specializing in platsymaplasty, delivering a high standard of care and contributing to market growth by ensuring patient satisfaction and safety.
Analyst Perspective
The platysmaplasty treatment market is witnessing steady growth, driven by increasing demand for neck contouring, jawline enhancement, and facial rejuvenation procedures. Rising disposable incomes, growing acceptance of cosmetic surgery, and advancements in surgical techniques are supporting market expansion. Despite high procedure costs in some regions, increasing awareness and the availability of skilled plastic surgeons are expected to drive long-term market growth.
Gender Insights
The female segment dominated the market with approximately 60.0% share in 2025 and is anticipated to witness the highest CAGR of around 7.0% during the forecast period. The dominance of the female segment in the market can be attributed to societal pressure and the desire to maintain a youthful neck and jawline. Women have shown a strong demand for platysmaplasty procedures, driven by growing awareness of aesthetic options and a willingness to invest in enhancing their appearance. For instance, in November 2025, Defyne Plastic Surgery announced its expansion to Los Angeles, extending access to advanced facial and neck rejuvenation procedures, including facelift and neck lift treatments. The expansion reflects the growing demand for aesthetic procedures among women seeking facial contouring and neck enhancement solutions.
The male segment is experiencing significant growth, driven by the increasing acceptance and normalization of cosmetic procedures. As societal attitudes evolve and men become more open to aesthetic enhancements, demand for platysmaplasty procedures has increased significantly. This shift is redefining the market, as men increasingly prioritize a sharp, well-defined jawline to maintain a competitive and youthful edge.
End-use Insights
The cosmetic surgery clinics segment dominated the market in 2025 with a revenue share of more than 60.0% and is anticipated to witness the highest CAGR of around 8.0% during the forecast period. Segment growth can be attributed to several factors, including increasing demand for noninvasive and minimally invasive cosmetic procedures and advancements in technology and procedures. Furthermore, cosmetic surgery clinics are expected to continue to dominate the market, with a growing focus on physical appearance, catering to an ever-expanding consumer base seeking safe, effective solutions for neck rejuvenation and cosmetic enhancement. For instance, in October 2025, Kaya Clinic launched the British Day Surgery Center by Kaya in Dubai, a state-of-the-art facility offering advanced plastic and reconstructive surgery services. The expansion strengthens access to specialized cosmetic procedures and highlights the growing investment in dedicated aesthetic surgery clinics.
The hospitals segment is experiencing significant growth in the market due to hospitals equipped with advanced infrastructure and surgical facilities, which instill confidence in patients seeking platysmaplasty procedures. In addition, hospitals often employ highly skilled, specialized medical professionals with extensive experience performing complex surgeries, such as platysmaplasty. For instance, in June 2025, UofL Health opened its first dedicated Cosmetic Surgery Center in East Louisville, expanding access to facial plastic and reconstructive surgery services. The new facility enhances the hospital’s capabilities in aesthetic and facial procedures, supporting the increasing adoption of hospital-based cosmetic treatments.
Regional Insights
North America dominated the market in 2025 with a revenue share of approximately 35.0%. The market dominance can be attributed to several key factors. The region boasts a highly developed healthcare infrastructure that offers advanced surgical techniques and cutting-edge technologies, making it an attractive destination for individuals seeking cosmetic procedures such as platysmaplasty. Moreover, North America's large patient population actively seeking aesthetic enhancements further drives demand for these treatments. The presence of skilled, experienced surgeons specializing in facial rejuvenation procedures enhances the region's competitive advantage. An example of North America's market dominance is evident in statistics from the American Society of Plastic Surgeons, which reported that the U.S. had the largest number of cosmetic treatments globally, encompassing a variety of surgical and minimally invasive procedures, including reconstructive procedures.
To learn more about this report,Download Free Sample Report
Asia Pacific Platysmaplasty Treatment Market Trends
The Asia Pacific is expected to witness the fastest CAGR of 9.0% over the forecast period. The growth is due to rising disposable income and improving standards of living, which have led to increased demand for cosmetic procedures, including facial aesthetics such as platysmaplasty. In addition, the growing awareness and acceptance of aesthetic treatments in the Asia Pacific have contributed to the surge in demand. Hospitals and cosmetic surgery centers are expanding rapidly in the region to provide advanced cosmetic and facial rejuvenation procedures to a broader patient base. These trends highlight the increasing demand for aesthetic treatments and facial enhancement procedures across the Asia Pacific region.
Key Platysmaplasty Treatment Market Company Insights
Market players are introducing advanced services at affordable prices to increase their share. Key players are implementing strategic initiatives, such as expansion, advanced service offerings, and marketing, to maximize their market dominance.
Key Platysmaplasty Treatment Companies
The following key companies have been profiled for this study on the platysmaplasty treatment market.
-
Long Island Plastic Surgical Group
-
Dr. Cat Plastic Surgery
-
Nazarian Plastic Surgery
-
Avenue Plastic Surgery
-
Piedmont Plastic Surgery & Dermatology
-
The Istanbul Aesthetic Center
-
The Esthetic Clinics
-
Los Angeles Plastic Surgery Clinic
Recent Developments
-
In April 2026, Regeneris Medical announced the launch of Flexlift, a next-generation face and neck rejuvenation procedure developed to deliver natural-looking facial and neck contouring results with minimal downtime. The procedure combines advanced face lift and neck lift techniques under local anesthesia, thereby enhancing treatment options for patients seeking neck rejuvenation and platysmaplasty related outcomes.
-
In March 2026, Kalos Facial Plastic Surgery, LLC, announced advancements in its Deep Plane Facelift technique through the integration of a comprehensive bucket handle platysmaplasty approach. The innovation focuses on enhanced platysma muscle release and resuspension to improve neck contour and jawline definition, thereby advancing surgical outcomes for patients undergoing platysmaplasty and neck rejuvenation.
-
In December 2025, Revance Therapeutics, Inc. announced the launch of the StriVectin TL Advanced Sculpting Neck & Jawline Mask. The product was developed to tighten, tone, and improve the appearance of the neck and jawline, thereby expanding the range of neck rejuvenation solutions available to consumers seeking aesthetic enhancement and anti-aging treatments.
Platysmaplasty Treatment Market Report Scope
Report Attribute
Details
Market size in 2025
USD 1.3 billion
Estimated market size in 2026
USD 1.4 billion
Projected market size by 2033
USD 2.3 billion
Growth rate
CAGR of 7.5% from 2026 to 2033
Base year for estimation
2025
Actual data
2021 - 2024
Forecast period
2026 - 2033
Quantitative units
Revenue in USD billion, and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Gender, end use, region
Regional scope
North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country scope
U.S.; Canada; Germany; U.K.; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled
Long Island Plastic Surgical Group; Dr. Cat Plastic Surgery; Nazarian Plastic Surgery; Avenue Plastic Surgery; Piedmont Plastic Surgery & Dermatology; The Istanbul Aesthetic Center; The Esthetic Clinics; Los Angeles Plastic Surgery Clinic
Customization scope
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail of customized purchase options to meet your exact research needs. Explore purchase options
Global Platysmaplasty Treatment Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global platysmaplasty treatment market report based on gender, end use, and region:
To learn more about this report,Download Free Sample Report
-
Gender Outlook (Revenue, USD Billion, 2021 - 2033)
-
Male
-
Female
-
-
End-use Outlook (Revenue, USD Billion, 2021 - 2033)
-
Cosmetic Surgery Clinics
-
Hospitals
-
-
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Sweden
-
Norway
-
Denmark
-
-
Asia Pacific
-
China
-
Japan
-
India
-
Australia
-
Thailand
-
South Korea
-
-
Latin America
-
Brazil
-
Mexico
-
Argentina
-
-
Middle East and Africa
-
Saudi Arabia
-
South Africa
-
UAE
-
Kuwait
-
-
Frequently Asked Questions About This Report
The global platysmaplasty treatment market is expected to grow at a CAGR of 7.5% from 2026 to 2033, reaching USD 2.3 billion.
The global platysmaplasty treatment market size was valued at USD 1.3 billion in 2025 and is estimated at USD 1.4 billion for 2026.
Some key players operating in the platysmaplasty treatment market include Long Island Plastic Surgical Group, Dr. Cat Plastic Surgery, Nazarian Plastic Surgery, Avenue Plastic Surgery, Piedmont Plastic Surgery & Dermatology, The Istanbul Aesthetic Center, The Esthetic Clinics, Los Angeles Plastic Surgery Clinic
The female platysmaplasty treatment segment accounted for the largest revenue share of approximately 60.0% in 2025.
North America dominated with an approximately 35.0% revenue share in 2025.
About the Author(s)
Medical Devices Research Team
Healthcare · Medical DevicesThis report was authored by the medical devices research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the medical devices segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs - add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.